Antivirals Market Analysis: By Type (Hepatitis-C, HIV, Herpes, Hepatitis-B, Influenza & Other Antivirals); By Action (DNA polymerase inhibitors, NS3 Protease inhibitors, Reverse transcriptase inhibitors and Others) – With Forecast (2016-2021)
[Report Updated: 25-02-2016]


Related Topics: GlaxoSmithKline , Hepatitis , Johnson and Johnson , Novartis

Sorry, this report is no longer available.

We may have other suitable reports available - try Searching for Antivirals
or contact our sales team for personal assistance: phone +44 (0)7887945155 or email pdb@bioportfolio.co.uk.

Introduction

Antivirals are drugs that are used to treat viral infections. While a majority of antivirals are used for treating specific viral infections, there are a few broad-spectrum antivirals to treat other viral infections. As opposed to antibiotics that actually destroy the target pathogen, antivirals only inhibit the growth of the pathogen. Antivirals have the advantage of not causing any side effects and focus on inibiting the replication of the virus. An increase in the disease afflicted population across the globe is one of the major drivers for this market. Apart from this, increasing levels of awareness coupled with the launch of newer and more effective drugs, this market has tremendous opportunities in emerging economies. The antiviral market is expected to grow at a steady and healthy growth rate till the end of the forecast period considered in this report. Expiry of patents is another factor providing opportunities for this market. Factors that include government policies can prove to be challenging factors in this market.

The report also provides an exhaustive overview of antiviral research and development pipeline. A huge amount of research and development is underway to extend the range of antivirals to treat other pathogens. Also, with the tendency of viruses to mutate and become drug resistant, the need of the hour is to develop and refresh the pipeline of antivirals with new therapies. A section on patent analysis is also included.

Antivirals Market


Antiviral drugs are used in the treatment of HIV, herpes viruses, the hepatitis B and C viruses, and influenza A and B viruses. The global antivirals market is expected to be dominated by HIV antivirals. According to the WHO and UNAIDS estimates, 36.7 million people were living with HIV globally at the end of 2015. In 2015, approximately 2.1 million people became newly infected and 1.1 million died of HIV-related causes.

The Antivirals market can be segmented on the basis of type as:

HIV Antivirals

Hepatitis-C Antivirals

Herpes Antivirals

Influenza Antivirals

Hepatitis-B Antivirals

Other Antivirals

In terms of actions, the Antivirals market has been segmented across the following:

DNA polymerase inhibitors

NS3 Protease inhibitors

Reverse transcriptase inhibitors

The market has been segmented based on the following geographies:

North America

South America

APAC

Europe

Middle East

Africa

Following are just a few of the companies that are operating in the Antivirals market:

GlaxoSmithKline plc

Merck & Co

Johnson and Johnson

Novartis International AG

Gilead Sciences Inc

Table of Contents
for Antivirals Market Analysis: By Type (Hepatitis-C, HIV, Herpes, Hepatitis-B, Influenza & Other Antivirals); By Action (DNA polymerase inhibitors, NS3 Protease inhibitors, Reverse transcriptase inhibitors and Others) – With Forecast (2016-2021) [Report Updated: 25-02-2016]

  • 1. Antivirals– Market Overview

    2. Executive Summary

    3. Antivirals– Market Landscape

    3.1. Market Share Analysis

    3.2. Comparative Analysis

    3.2.1. Product Benchmarking

    3.2.2. End User Profiling

    3.2.3. Top 5 Financials Analysis

    4. Antivirals– Market Forces

    4.1. Market Drivers

    4.2. Market Constraints

    4.3. Market Challenges

    4.4. Attractiveness of the Antivirals Market

    4.4.1. Power of Suppliers

    4.4.2. Power of Customers

    4.4.3. Threat of New Entrants

    4.4.4. Threat of Substitution

    4.4.5. Degree of Competition

    5. Antivirals Market – Strategic Analysis

    5.1. Value Chain Analysis

    5.2. Pricing Analysis

    5.3. Opportunities Analysis

    5.4. Product/Market Life Cycle Analysis

    5.5. Suppliers and Distributors

    6. Antivirals Market– By Type

    6.1. Hepatitis-C antivirals

    6.2. HIV antivirals

    6.3. Herpes antivirals

    6.4. Hepatitis-B antivirals

    6.5. Influenza antivirals

    6.6. Others

    7. Antivirals Market– By Actions

    7.1. DNA polymerase inhibitors

    7.2. NS3 Protease inhibitors

    7.3. Reverse transcriptase inhibitors

    7.4. Others

    8. Antivirals Market– By Geography

    8.1. Introduction

    8.2. Global Study

    8.3. Americas

    8.3.1. North America

    8.3.2. Brazil

    8.3.3. Argentina

    8.3.4. Others

    8.4. Europe

    8.4.1. U.K.

    8.4.2. France

    8.4.3. Germany

    8.4.4. Others

    8.5. APAC

    8.5.1. China

    8.5.2. Japan

    8.5.3. India

    8.5.4. Others

    8.6. ROW

    9. Antivirals Market Entropy

    9.1. New Product Launches

    9.2. M&As, Collaborations, JVs and Partnerships

    10. Company Profiles

    10.1. Novartis AG

    10.2. Gilead Sciences Inc.

    10.3. Merck

    10.4. Johnson and Johnson

    10.5. GlaxoSmithKline

    10.6. Abbott Laboratories

    10.7. AstraZeneca AB

    10.8. BoehringerIngelheim Corporation

    10.9. Schering-Plough

    10.10. Roche

    *More than 40 Companies are profiled in this Research Report, Complete List available on Request*

    "*Financials would be provided on a best efforts basis for private companies"

    11. Appendix

    11.1. Abbreviations

    11.2. Sources

    11.3. Research Methodology

    11.4. Bibliography

    11.5. Compilation of Expert Insights

    11.6. Disclaimer

List Of Tables
in Antivirals Market Analysis: By Type (Hepatitis-C, HIV, Herpes, Hepatitis-B, Influenza & Other Antivirals); By Action (DNA polymerase inhibitors, NS3 Protease inhibitors, Reverse transcriptase inhibitors and Others) – With Forecast (2016-2021) [Report Updated: 25-02-2016]

No

Additional Details

Publisher

Publisher Information

Reference

80069 | HCR 0130

Report Format

PDF

 Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Hepatitis C Therapeutics in Asia-Pacific Markets to 2023 - Presence of Outstanding Direct-Acting Antivirals and Late-Stage Pipeline to Transform the Clinical and Commercial Landscape
Hepatitis C Therapeutics in Asia-Pacific Markets to 2023 - Presence of Outstanding Direct-Acting Ant...
01 Aug 2017 by GBI Research USD $4,995 More Info
Anti-Infective Drugs Market Global Report 2017 Including: Antibiotics, Antivirals, Antifungals, Others (Antihelmethic, Antiprotozoal) Covering: Pfizer Inc., GlaxosmithKline, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, and Sanofi
Anti-infecive drugs market covers the drugs that are used for the treatment of infectious diseases s...
17 Jul 2017 by The Business Research Company USD $4,000 More Info
Anti-Infective Drugs Market Global Report 2017 Including: Antibiotics, Antivirals, Antifungals, Others (Antihelmethic, Antiprotozoal) Covering: Pfizer Inc., GlaxosmithKline, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, and Sanofi
Companies in the anti-infective drugs market are very active with multiple strategic collaborations ...
17 Jul 2017 by The Business Research Company USD $4,000 More Info
Competitor Analysis: Respiratory Syncytial Virus (RSV) Antibodies, Vaccines & Antivirals 2017
Competitor Analysis: Respiratory Syncytial Virus (RSV) Antibodies, Vaccines & Antivirals 2017 ...
27 Mar 2017 by La Merie USD $450 More Info
Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations
Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Anti...
01 Dec 2016 by GBI Research USD $6,995 More Info
Anti-Infective Drugs Market: By Drug Type (Antifungals, Antibacterials, Antivirals), By Infection Type(HIV, Hepatitis B, Hepatitis C, Urinary Tract, Respiratory Candidiasis, Other Infections) & Geography - Forecast (2016-2021)
Anti-infective drugs can be defines as drugs which are capable of killing an infectious agent or inh...
25 Feb 2016 by USD $5,250 More Info

We Stock...